O-I Glass Inc’s filing revealed that its SVP & Chief Financial Officer Haudrich John acquired Company’s shares for reported $29879.0 on Aug 05 ’25. In the deal valued at $13.05 per share,2,289 shares were bought. As a result of this transaction, Haudrich John now holds 459,395 shares worth roughly $7.15 million.
Then, ABRAHAMS DARROW A bought 3,828 shares, generating $49,952 in total proceeds. Upon buying the shares at $13.05, the SVP, GC & Corporate Secretary now owns 184,447 shares.
Before that, Hardie Gordon bought 8,000 shares. O-I Glass Inc shares valued at $104,805 were divested by the President & CEO at a price of $13.10 per share. As a result of the transaction, Hardie Gordon now holds 515,817 shares, worth roughly $8.03 million.
Wells Fargo upgraded its O-I Glass Inc [OI] rating to an Overweight from a an Equal weight in a research note published recently. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in mid November from “a Neutral” to “a Buy”. Wells Fargo also remained covering OI and has decreased its forecast on July 18, 2025 with a “an Equal weight” recommendation from previously “an Overweight” rating. BofA Securities revised its rating on July 09, 2025. It rated OI as “a Neutral” which previously was an “a Buy”.
Price Performance Review of OI
On Monday, O-I Glass Inc [NYSE:OI] saw its stock jump 0.52% to $15.56. Over the last five days, the stock has gained 2.03%. O-I Glass Inc shares have risen nearly 48.90% since the year began. Nevertheless, the stocks have risen 5.42% over the past one year.
How much short interest is there in O-I Glass Inc?
A steep rise in short interest was recorded in O-I Glass Inc stocks on 2025-12-31, growing by 1.22 million shares to a total of 12.13 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 10.9 million shares. There was a rise of 10.1%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 25, 2025 when BNP Paribas Exane began covering the stock and recommended ‘”an Outperform”‘ rating along with a $18 price target.
